Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1687622

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1687622

Peripheral Interventions Market Size, Share, and Growth Analysis, By Intervention Type (Atherectomy, Stent Implantation), By Device Type (Catheters, Stents), By Indication, By Technology, By End User, By Region - Industry Forecast 2025-2032

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Peripheral Interventions Market size was valued at USD 10.2 billion in 2023 and is poised to grow from USD 11.13 billion in 2024 to USD 22.34 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The rising incidence of cardiovascular disorders (CVD) is significantly driving demand for peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and high-carb diets. To address this health issue, there is a notable increase in catheterization laboratories (cath labs) globally, particularly in emerging markets, accompanied by a growing number of healthcare professionals specializing in this field. Cath labs are becoming essential for diagnosing and treating CVD, and their presence is expanding, especially in developing nations. The advent of hybrid labs, which support various procedures beyond cardiovascular interventions, highlights industry innovation. For instance, India's cath labs have more than doubled recently, coinciding with a surge in angioplasties, thereby boosting global healthcare spending and anticipating further growth in peripheral intervention services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Interventions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Interventions Market Segments Analysis

Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Interventions Market

The increasing prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD), is a significant factor fueling the demand for peripheral intervention solutions. This surge in cases of cardiovascular conditions can largely be linked to risk factors such as hypertension, diabetes, obesity, and a lack of physical activity. As more individuals face these health challenges, there is an urgent need for effective peripheral therapies that address these issues. Consequently, healthcare providers and manufacturers are responding to this growing demand by developing and offering innovative treatment options tailored to manage and mitigate the effects of these cardiovascular disorders.

Restraints in the Peripheral Interventions Market

The Peripheral Interventions market faces significant limitations due to the high costs associated with these treatments, which can be a barrier for many individuals seeking care. In particular, those living in developed regions may find that expensive healthcare options hinder their access to necessary procedures. The financial strain imposed by these interventions can deter patients from pursuing them, ultimately affecting the overall growth and accessibility of the market. Consequently, the high cost of peripheral interventions remains a critical restraint that impacts patient choices and the market's expansion potential in various geographic areas.

Market Trends of the Peripheral Interventions Market

The Peripheral Interventions market is experiencing a significant trend towards the establishment of heterogeneous catheterization labs that integrate various invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures. These hybrid facilities are gaining traction due to their flexibility, which allows healthcare providers to streamline operations and enhance patient outcomes by combining different specialties under one roof. This trend is driven by the demand for minimally invasive treatment options and the need for efficient patient management, propelling market growth. As technology advances and the focus shifts to personalized care, the hybridization of catheterization labs is set to revolutionize the landscape of peripheral interventions.

Product Code: SQMIG35D2214

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Peripheral Interventions Market Size by Intervention Type & CAGR (2025-2032)

  • Market Overview
  • Atherectomy
  • Stent Implantation
  • Angioplasty
  • Thrombectomy
  • Embolization

Global Peripheral Interventions Market Size by Device Type & CAGR (2025-2032)

  • Market Overview
  • Catheters
  • Stents
  • Guide Wires
  • Balloons
  • Embolic Coils

Global Peripheral Interventions Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Coronary Artery Disease
  • Stroke
  • Peripheral Arterial Disease
  • Renal Artery Stenosis
  • Carotid Artery Stenosis

Global Peripheral Interventions Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Drug-Eluting Stents
  • Balloon-Expandable Stents
  • Self-Expanding Stents
  • Rotational Atherectomy
  • Directional Atherectomy

Global Peripheral Interventions Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Research Institutes

Global Peripheral Interventions Market Size & CAGR (2025-2032)

  • North America (Intervention Type, Device Type, Indication, Technology, End User)
    • US
    • Canada
  • Europe (Intervention Type, Device Type, Indication, Technology, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Intervention Type, Device Type, Indication, Technology, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Intervention Type, Device Type, Indication, Technology, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Intervention Type, Device Type, Indication, Technology, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ArtVentive Medical Group, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inari Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bentley InnoMed GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gore Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!